Stay updated on Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page.

Latest updates to the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.5.0 is now displayed, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision history updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.0%

- Check55 days agoChange DetectedSite-wide maintenance updates include a new Revision: v3.4.2 and the removal of a prior government funding/operating status notice. These changes do not modify the study details, eligibility criteria, outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedAdded a government funding lapse notice and updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check69 days agoChange DetectedAdditions include showing the glossary and new footer metadata: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Deletions remove the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check83 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. No substantive changes to study details or navigation are indicated.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page.